V

vTv Therapeutics
D

VTVT

23.130
USD
-0.20
(-0.86%)
مغلق
حجم التداول
0
الربح لكل سهم
-4
العائد الربحي
-
P/E
-8
حجم السوق
60,536,183
أصول ذات صلة الأخبار المقالات

العنوان: vTv Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
vTv Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin, being investigated for the treatment of type 1 diabetes (T1D). Its product pipeline includes TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.